Endovascular Treatment and Outcomes for Femoropopliteal In-Stent Restenosis: Insights from the XLPAD Registry

Table 2

Target lesion characteristics for femoropopliteal (FP) non-in-stent restenosis and in-stent restenosis (ISR) groups.

		Non-ISR (n = 3288)		ISR (n = 370)		value
Lesion length (mm)		142.0 ± 99.5		145 ± 99.1		0.55
Severe calcification (heavily calcified)		1470	44.7%	83	22.4%	<0.001
Diffuse disease		2204	67.0%	205	55.4%	<0.001
Chronic total occlusion		1770	53.7%	175	47.3%	0.02
Run-off vessels	0–1	568	25.40%	102	33.6%	0.01
	2	697	31.2%	81	26.6%
	3	971	43.4%	121	39.80%